Working… Menu
Trial record 1 of 1 for:    obeticholic acid, regenerate
Previous Study | Return to List | Next Study

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02548351
Recruitment Status : Active, not recruiting
First Posted : September 14, 2015
Last Update Posted : September 9, 2021
Information provided by (Responsible Party):
Intercept Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2025
Estimated Study Completion Date : September 2025
Publications automatically indexed to this study by Identifier (NCT Number):